Mesothelioma is one of the most serious diseases associated with asbestos exposure. For many Canadians, a diagnosis comes decades after working in industrial settings, construction, shipyards, steel plants, refineries, or power generation facilities. The delay between exposure and diagnosis often creates confusion about how the disease developed and what options are available.

This guide provides a comprehensive overview of mesothelioma in Canada. It explains what mesothelioma is, outlines the different types and stages, discusses prognosis and life expectancy, and explores how asbestos exposure happens in Canadian workplaces and homes. It also provides an overview of the legal and compensation pathways available to eligible Canadians, including asbestos trust claims and workers’ compensation.

Mesothelioma is a rare and aggressive cancer caused by exposure to asbestos fibres. When asbestos fibres are inhaled or ingested, they can become lodged in the lining of certain organs. Over time, those fibres can cause inflammation and genetic damage that leads to cancer.

The disease most commonly affects the lining of the lungs, but it can also develop in the lining of the abdomen, heart, or testes. Because symptoms often resemble more common conditions, mesothelioma is frequently diagnosed at a later stage.

Common symptoms may include persistent cough, chest pain, shortness of breath, abdominal swelling, fatigue, and unexplained weight loss. For a more detailed breakdown of early and late warning signs, see our dedicated page on mesothelioma symptoms.

Mesothelioma is distinct from other asbestos-related conditions such as asbestosis or lung cancer. It is specifically tied to asbestos exposure and has a long latency period, typically 20 to 50 years.

Pathologists also classify mesothelioma based on the appearance of cancer cells under a microscope:

Staging refers to how far the cancer has progressed at the time of diagnosis. Doctors use staging systems to determine treatment options and to estimate prognosis.

For pleural mesothelioma, staging typically ranges from Stage I to Stage IV. Early-stage disease may be localized, while advanced-stage disease may involve spread to lymph nodes or distant organs.

Staging affects whether surgery is an option, whether chemotherapy or immunotherapy is recommended, and how aggressive treatment may be. Earlier stages may allow for multimodal treatment strategies combining surgery, chemotherapy, and radiation.

For a complete explanation of the staging system, diagnostic imaging, and how staging influences treatment decisions, see our detailed guide on mesothelioma stages.

Prognosis refers to the expected course and outcome of the disease. Life expectancy is one component of prognosis and typically reflects median survival statistics based on stage, cell type, age, and overall health.

Mesothelioma prognosis varies significantly depending on several factors:

• Stage at diagnosis
• Cell type
• Patient age and overall health
• Response to treatment

While survival statistics provide general guidance, they do not determine individual outcomes. Some patients respond exceptionally well to treatment and live significantly longer than statistical averages.

For in-depth information, including survival ranges and emerging treatment developments, visit our pages on mesothelioma prognosis and mesothelioma life expectancy. In many cases, these topics overlap, and understanding both together provides a clearer picture of expectations.

Secondary exposure occurs when workers inadvertently bring asbestos fibres home on clothing, boots, or tools. Family members may inhale fibres while laundering contaminated clothing. These cases are recognized and may be eligible for compensation in certain circumstances.